Controlled Ventilation CT in CF Infants
| Status: | Terminated |
|---|---|
| Conditions: | Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any - 5 |
| Updated: | 4/25/2018 |
| Start Date: | September 1, 2015 |
| End Date: | June 30, 2017 |
Differentiating Outcome Measures in Infants/Young Children With Cystic Fibrosis Utilizing Controlled Ventilation Infant/Young Child Chest CT Scanning and Lung Function Testing
The objective of the study is to implement a new method of performing chest CT imaging in
young children with cystic fibrosis at Packard Children's Hospital. This technique will be
used to evaluate early lung disease comparing quantitative chest CT air trapping and airway
measurements with lung function measurements in infants, toddlers, and young children with
chronic lung disease.
young children with cystic fibrosis at Packard Children's Hospital. This technique will be
used to evaluate early lung disease comparing quantitative chest CT air trapping and airway
measurements with lung function measurements in infants, toddlers, and young children with
chronic lung disease.
Inclusion Criteria:
1. Infants and young children (age ~ 2/3 months to < 5 years)
2. Diagnosed with cystic fibrosis with either 2 identified CFTR gene mutations, or a
positive sweat chloride
3. Informed consent by parent or legal guardian.
4. Ability to comply with study visit procedures as judged by the investigator.
Exclusion Criteria:
1. Acute wheezing and/or respiratory distress at either study visit.
2. Acute intercurrent respiratory infection, defined as an increase in cough, wheezing,
or respiratory rate with onset in 1 week preceding Study visit.
3. Oxygen saturation < 90% on room air at study visit.
4. Any medical condition that in the opinion of the investigator precludes subject
participation.
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
